Us Bancorp \De\ Ventyx Biosciences, Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$29.8 - $40.3 $22,797 - $30,829	-765 Reduced 12.5%	5,357 $186,000
Q2 2023 Aug 09, 2023	SELL	$28.53 - $39.55 $22,110 - $30,651	-775 Reduced 11.24%	6,122 $200,000
Q1 2023 May 09, 2023	SELL	$29.51 - $46.65 $215,482 - $340,638	-7,302 Reduced 51.43%	6,897 $231,000
Q4 2022 Feb 13, 2023	BUY	$24.16 - $36.38 $343,047 - $516,559	14,199 New	14,199 $465,000

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $116M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.